Fuller & Thaler Asset Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-69,592
Closed -$11.5M 552
2021
Q2
$11.5M Sell
69,592
-5,617
-7% -$877K 0.07% 213
2021
Q1
$10.5M Buy
75,209
+901
+1% +$147K 0.07% 211
2020
Q4
$12.9M Buy
74,308
+1,396
+2% +$226K 0.12% 167
2020
Q3
$10.2M Buy
72,912
+852
+1% +$114K 0.13% 163
2020
Q2
$8.61M Buy
72,060
+495
+0.7% +$58.7K 0.11% 178
2020
Q1
$7.16M Sell
71,565
-1,499
-2% -$180K 0.12% 162
2019
Q4
$8.59M Buy
+73,064
New +$7.24M 0.1% 171

Other funds holding NVRO

Fuller & Thaler Asset Management's NVRO Position: Q3 2021 in Review

Fuller & Thaler Asset Management sold out of NEVRO CORP. (NVRO) in Q3 2021, closing a stake of 69,592 shares — an estimated $11.5M sold.

Fuller & Thaler Asset Management first reported a position in NVRO in Q4 2019 and held it in 7 quarters. The position peaked at $12.9M in Q4 2020. 194 funds tracked by Wall St. Rank hold NVRO as of Q3 2021.

  • Fuller & Thaler Asset Management reported no remaining NEVRO CORP. position as of Q3 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 69,592 NEVRO CORP. shares in Q3 2021, an estimated $11.5M.
  • Fuller & Thaler Asset Management first reported a position in NEVRO CORP. in Q4 2019 and held it in 7 quarters.
  • Fuller & Thaler Asset Management's NEVRO CORP. position peaked at $12.9M in Q4 2020.
  • 194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.